Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...

The U.S. Food and Drug Administration (FDA) said it will not review Moderna’s application for the first mRNA-based flu shot.

Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds.

The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...

USDA grant is part of a broader federal push to find innovative solutions to fight the highly infectious avian ...

MNK1 and MNK2 belong to the same enzyme family and are best known for regulating how cells make proteins. Their starring role ...

When developing new drugs, one thing is particularly important: finding and producing the right molecules that can be used as ...

A new study reveals that the twin enzymes MNK1 and MNK2 play distinct roles in the brain, with one governing memory and the other social behavior.

CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.

The FDA plans to adopt a new policy that will do away with the default requirement to base regulatory filings for new medicines on two pivotal trials, according to Commissioner Marty Makary.

The agreement gives MSD (known as Merck & Co in the US and Canada) access to the Mayo Clinic Platform architecture – which covers de-identified laboratory results, medical imaging, clinical notes, ...

It already exists in the natural world. Now, thanks to breakthroughs in genetic engineering, scientists have created “supersilk.” And it’s poised to upgrade far more than our clothing.